Literature DB >> 1517627

System functionality and physicochemical model of fentanyl transdermal system.

S K Gupta, M Southam, R Gale, S S Hwang.   

Abstract

Fentanyl is an opioid traditionally administered by infusion or injection and more recently in a rate-controlled transdermal dosage form. This system is a four-layer laminate on a protective liner. A backing layer seals and protects the drug reservoir, the source for continuous delivery of fentanyl. A membrane controls the release rate of fentanyl from the system. An adhesive layer attaches the system to skin and releases an initial loading dose of fentanyl. The rate of fentanyl delivery through skin is determined by the system and the skin at the application site. The release rate from the system is approximated by Fick's first law of diffusion and is controlled by the rate-controlling membrane. A complete simulation model that combines both in vitro release data and the pharmacokinetic model has been developed and used to show the influence of various physiologic and system variables on serum fentanyl concentrations.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1517627     DOI: 10.1016/0885-3924(92)90049-n

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  17 in total

Review 1.  Clinical pharmacology of analgesic medicines in older people: impact of frailty and cognitive impairment.

Authors:  Andrew J McLachlan; Sally Bath; Vasi Naganathan; Sarah N Hilmer; David G Le Couteur; Stephen J Gibson; Fiona M Blyth
Journal:  Br J Clin Pharmacol       Date:  2011-03       Impact factor: 4.335

2.  Reservoir based fentanyl transdermal drug delivery systems: effect of patch age on drug release and skin permeation.

Authors:  Suneela Prodduturi; Glen J Smith; Anna M Wokovich; William H Doub; Benjamin J Westenberger; Lucinda Buhse
Journal:  Pharm Res       Date:  2009-02-20       Impact factor: 4.200

Review 3.  Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control.

Authors:  W Jeal; P Benfield
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

4.  Evaluation of Heat Effects on Fentanyl Transdermal Delivery Systems Using In Vitro Permeation and In Vitro Release Methods.

Authors:  Qian Zhang; Michael Murawsky; Terri D LaCount; Jinsong Hao; Priyanka Ghosh; Sam G Raney; Gerald B Kasting; S Kevin Li
Journal:  J Pharm Sci       Date:  2020-07-20       Impact factor: 3.534

Review 5.  Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl.

Authors:  S Grond; L Radbruch; K A Lehmann
Journal:  Clin Pharmacokinet       Date:  2000-01       Impact factor: 6.447

6.  Death by band-aid: fatal misuse of transdermal fentanyl patch.

Authors:  Marija Bakovic; Marina Nestic; Davor Mayer
Journal:  Int J Legal Med       Date:  2015-06-09       Impact factor: 2.686

7.  Modified glasgow prognostic score predicting high conversion ratio in opioid switching from oral oxycodone to transdermal fentanyl in patients with cancer pain.

Authors:  Shu-Shan Jia; Li Shang; Ming-E Li; Dong-Mei Zhao; Wen-Hua Xu; Yao-Qi Wang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 8.  Transdermal fentanyl: pharmacology and toxicology.

Authors:  Lewis Nelson; Robert Schwaner
Journal:  J Med Toxicol       Date:  2009-12

9.  [Transdermal fentanyl for the treatment of cancer pain.].

Authors:  B Donner; M Zenz; M Tryba; M Strumpf
Journal:  Schmerz       Date:  1993-03       Impact factor: 1.107

10.  Evaluation of Heat Effects on Transdermal Nicotine Delivery In Vitro and In Silico Using Heat-Enhanced Transport Model Analysis.

Authors:  Terri D La Count; Qian Zhang; Michael Murawsky; Jinsong Hao; Priyanka Ghosh; Kaushalkumar Dave; Sam G Raney; Arjang Talattof; Gerald B Kasting; S Kevin Li
Journal:  AAPS J       Date:  2020-06-02       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.